Document is current
Any future updates will be listed below
-
Authors
Wang, Jinhong
Ma, Zhihui
Xu, Qianyue
Wei, Benliang
Wang, Mengmeng
Liu, Yanhong
Tian, Yu
Zhang, Haifeng
Xiao, Liang
Zhong, Yiyi
Zou, Yuanqiang
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China under Grant Agreement (No. 32100009, No. 32100009, No. 32100009, No. 32100009, No. 32100009, No. 32100009)
Shenzhen Municipal Government of China under Grant Agreement (No. XMHT20220104017, No. XMHT20220104017, No. XMHT20220104017, No. XMHT20220104017, No. XMHT20220104017, No. XMHT20220104017)
- License Information
-
More Information
Article History
Accepted: 7 March 2025
First Online: 19 March 2025
Declarations
:
: This study has been approved by Guangdong Lewwin Pharmaceutical Research Institute Co., Ltd. (Guangzhou, China; Ethics approval reference no.: IA-PD2022034-01). This study followed the Regulations for the Administration of Affairs Concerning Experimental Animals of China.
: Jinhong Wang and Zhihui Ma have received research support from BGI Precision Nutrition (Shenzhen) Technology Co., Ltd, (Shenzhen, China), which had involvement in the study design, data collection, analysis and interpretation, writing of the report, and the decision to submit the article for publication. Haifeng Zhang is the chairman of BGI Precision Nutrition (Shenzhen) Technology Co., Ltd, (Shenzhen, China). The content of this article may be used as the basis for future products developed by the sponsor company. Despite this involvement, the authors maintain that the study was conducted objectively and the findings presented herein are an accurate reflection of the research conducted.
